Anna Eshoo: “It has cost us lives.”

I find it hypocritical when I hear time and time and time again that plans are often blocked by PBMs from offering the lowest-priced generic.

The Medicaid Value-Based Payments for Patients Act will codify a CMS rule to help ensure Medicaid enrollees have access to breakthrough gene therapies.

Spectrum is the gold in the 21st century. Nothing moves without spectrum.

Simply put, we are not getting the best value for our healthcare dollar.